Oct 16, 2020 | Drug Costs
The debate over whether the rebate system that currently exists in the U.S. is beneficial for patients or payers or pharmacy benefit managers (PBMs) has been endless. Now, a new report from the Center for Medical Economics and Innovation at the Pacific Research...
Read more
Sep 24, 2020 | Drug Costs, State Issues
An international drug pricing model developed by the National Academy for State Health Policy has been proposed to be adopted in Pennsylvania to reduce drug costs in the state. Senator Tom Killion introduced the Prescription Drug Cost Reduction Act (Senate Bill 1315)...
Read more
Sep 16, 2020 | Drug Costs, Featured, Podcast
On this episode of the podcast, Terry and Bob discuss what goes into a drug price. They pull the curtain to reveal the group of middlemen between drugmakers and the patient that drives up the drug prices patients pay. They highlight the bizarre system of drug rebates,...
Read more
Aug 2, 2020 | Drug Costs, Featured, Podcast
On this week’s episode of the Patient’s Rising podcast, Terry and Bob discuss President Trump’s executive orders on prescription drug prices. Recently, Trump signed a series of Executive Orders that direct U.S. Health and Human Services to take steps...
Read more
Feb 22, 2020 | Copay Accumulators, Copay Assistance, Drug Costs, Federal Issues, News
Patients struggling with the high cost of health insurance can expect even higher out-of-pocket costs in 2021, under an insurance regulation proposed by the Centers for Medicare & Medicaid Services. Last month, the obscure federal agency under the Department of...
Read more
Nov 11, 2019 | Drug Costs
What Is the 340B Drug Pricing Program? Established by Congress in 1992 and managed by the Health Resources and Services Administration (HRSA), the 340B Drug Pricing Program mandates drug manufacturers participating in Medicaid to provide certain outpatient drugs...
Read more
